Patel Dinesh V PH D 的 Form 4 申報
Protagonist Therapeutics, IncPTGX，2026/1/27 申報
- 申報編號
- 0001104659-26-007129
- 申報時間
- 2026/1/27
- 交易日
- 2026/1/23-1/27
- 申報延遲
- 4 天
- 10b5-1 計畫
- 沒有勾選
這份申報列了 9 筆非衍生性交易、4 筆衍生性交易。公開市場賣出合計 $406.4 萬。交易後 4 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Patel Dinesh V PH DCIK 0001120477 | 董事、高階主管（總裁、執行長） |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2026/1/23 | Common Stock | G贈與處分 | −6,000 | $0.00 | $0 | 574,505 | 直接 | |
| 2026/1/23 | Common Stock | M行使選擇權取得 | +19,315 | $4.21 | +$81,316.15 | 593,820 | 直接 | |
| 2026/1/23 | Common Stock | S賣出處分 | −19,315 | $84.59F2 | −$1,633,855.85 | 574,505 | 直接 | |
| 2026/1/26 | Common Stock | M行使選擇權取得 | +10,685 | $4.21 | +$44,983.85 | 585,190 | 直接 | |
| 2026/1/26 | Common Stock | S賣出處分 | −10,685 | $84.00F3 | −$897,540 | 574,505 | 直接 | |
| 2026/1/26 | Common Stock | M行使選擇權取得 | +14,205 | $21.58 | +$306,543.9 | 588,710 | 直接 | |
| 2026/1/26 | Common Stock | S賣出處分 | −14,205 | $84.05F4 | −$1,193,930.25 | 574,505 | 直接 | |
| 2026/1/27 | Common Stock | M行使選擇權取得 | +4,068 | $21.58 | +$87,787.44 | 578,573 | 直接 | |
| 2026/1/27 | Common Stock | S賣出處分 | −4,068 | $83.19F5 | −$338,416.92 | 574,505 | 直接 |
衍生性證券（表 II）
選擇權、認股權證、限制型股票單位等。股數是標的股票的股數；單價與金額是衍生證券本身的價格，交易後持有是衍生證券的單位數。
| 交易日 | 證券 | 交易 | 標的股數 | 單價 | 金額 | 交易後持有 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2026/1/23 | Common Stock | M行使選擇權處分 | −19,315 | $0.00 | $0 | 10,685 | 直接 | |
| 2026/1/26 | Common Stock | M行使選擇權處分 | −10,685 | $0.00 | $0 | 0 | 直接 | |
| 2026/1/26 | Common Stock | M行使選擇權處分 | −14,205 | $0.00 | $0 | 304,068 | 直接 | |
| 2026/1/27 | Common Stock | M行使選擇權處分 | −4,068 | $0.00 | $0 | 300,000 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F2
The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $84.41 to $84.64. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F3
The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $84 to $84.095. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F4
The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $84 to $84.075. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F5
The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $83.06 to $83.59. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
表 I 有 1 筆交易的價格引用這則附註。